Profil新闻

我们的专家

Lars Bochmann 博士

市场与业务发展执行总监

九月 30, 2024

AI in Clinical Research: Transforming the Future of Medicine

Artificial Intelligence (AI) has rapidly become a transformative force across numerous industries, and clinical research is no exception. The integration of AI into clinical research is

九月 10, 2024

Live Online Seminar: MASH Pharmacotherapy - On the Brink of a New Era

We are happy to announce that our successful series of scientific online seminars continues. On October 08th, 2024 at 4:00PM CEST we will air our next complimentary live online seminar. The session

八月 27, 2024

A Seven-Step Guide to Navigating New EU Regulations for Medical Devices

The regulatory landscape for medical device manufacturers in the EU has changed significantly with the introduction of new regulations. Navigating these requirements can be challenging, but with the

七月 31, 2024

The German Medical Research Act: Transforming Clinical Trials

Germany is on the brink of a pivotal transformation in the pharmaceutical research landscape with the upcoming Medical Research Act. This legislative milestone is part of the government's broader

七月 4, 2024

Live Online Seminar: Initiative Germany as a Location for Clinical Trials

We are happy to announce that our successful series of scientific online seminars continues. On July 30th, 2024 at 6 PM CEST we will air our next complimentary live online seminar. The session is

五月 29, 2024

Accelerating Innovation: The Impact of CROs on European Biotech SMEs

In the constantly evolving landscape of the biotech industry, small and medium-sized enterprises (SMEs) in Europe are finding an invaluable ally in Contract Research Organizations (CROs). Among

四月 30, 2024

Navigating Financial Incentives for SMEs in Europe's Biotech Landscape

In the challenging yet promising field of biotechnology, particularly within the domains of obesity and diabetes research, the journey from concept to commercial success is intricate and

三月 26, 2024

First drug approved for NASH

On March 14, 2024, Madrigal Pharmaceuticals received the first regulatory approval for a drug targeting NonAlcoholic SteatoHepatitis (NASH). Specifically, FDA approved Rezdiffra (resmetirom) for the

一月 9, 2024

BfArM speeds up the approval process for clinical trials in Germany

With the implementation of the Clinical Trials Regulation 536/2014 (CTR) and the Clinical Trials Information System (CTIS) on 31st of January 2022, the European Union has embarked on a transformative